Description

Omiganan (CAS 204248-78-2) is a synthetic cationic antimicrobial peptide derived from indolicidin, consisting of 12 amino acids. It exhibits broad-spectrum antimicrobial activity against both Gram-positive and Gram-negative bacteria, as well as certain fungal species.

This peptide has been investigated for various applications, including the treatment of Mupirocin-resistant MRSA skin infections, acne, and facial seborrheic dermatitis. It has also shown potential in recovering skin dysbiosis in conditions like atopic dermatitis.

Synthetized under GMP conditions, Omiganan boasts a purity of ?98.64%, ensuring high-quality standards for laboratory applications.

Product Specifications

Mechanism of Action & Research Applications

Omiganan functions by disrupting bacterial cell membranes through electrostatic interactions, leading to cell lysis and death. Its broad-spectrum activity makes it a valuable tool in studying antimicrobial resistance and developing new therapeutic agents.

In laboratory research, Omiganan is utilized to investigate its efficacy against various bacterial pathogens, its potential in treating skin infections, and its role in modulating skin microbiota in conditions like atopic dermatitis.

Disclaimer

This product is intended strictly for laboratory research use only. It is not approved for human or veterinary use. Handle according to institutional safety protocols.